Targeting the Pro-Survival Protein MET with Tivantinib (ARQ 197) Inhibits Growth of Multiple Myeloma Cells()()

The hepatocyte growth factor (HGF)/MNNG HOS transforming gene (MET) pathway regulates cell growth, survival, and migration. MET is mutated or amplified in several malignancies. In myeloma, MET is not mutated, but patients have high plasma concentrations of HGF, high levels of MET expression, and gen...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaman, Shadia, Shentu, Shujun, Yang, Jing, He, Jin, Orlowski, Robert Z., Stellrecht, Christine M., Gandhi, Varsha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372650/
https://www.ncbi.nlm.nih.gov/pubmed/25810013
http://dx.doi.org/10.1016/j.neo.2015.01.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372650/
https://www.ncbi.nlm.nih.gov/pubmed/25810013
http://dx.doi.org/10.1016/j.neo.2015.01.006

Ejemplares similares